Merck & Co Inc. has announced a start of last-stage trials for its HIV drug, known as islatravir. The event comes months after the U.S. Food and Drug Administration (FDA) suspended the study, citing safety issues.
Nvidia Corp unveiled new flagship gaming chips. It is known that they will be aimed at artificial intelligence to enhance graphics. The company relies on one of the world's leading semiconductor manufacturers, Taiwan Semiconductor Manufacturing (TSMC), to produce graphics chips.
One of the most significant players of the microchip manufacturing market, Nvidia Corp, has presented its latest development, which is a new computing system named DRIVE Thor. The platform in question provides centralization of different driving systems, including autonomous and assisted ones, and has a range of other digital options, among which are entertaining elements.
Musk's Texas-based company is preparing to produce thousands of anthropomorphic robots. They are known as the Tesla Bot or Optimus and will be produced in their own factories. The number of production facilities is planned to expand to several million worldwide in the future. This information can be found in the job advertisements.
Amazon, the U.S. technology giant, is one of five companies chosen by the European Central Bank to develop a prototype for the digital euro.
Moderna Inc. has authorized the use of its Covid-19 vaccine to develop mRNA vaccines for the World Health Organization that will expand vaccine production and make them more accessible to poor countries.
Tesla Inc. is planning to double car sales in Germany. The company management expects sales to be 80,000 units this year, as reported Sunday by German weekly Automobilwoche, given the data from a manager of the company.
A new product catalog released by the electric car manufacturer revealed the launch of Cyberwhistle, a whistle that draws design inspiration from the Tesla Cybertruck.
Pfizer Inc. has begun conducting the final phase of a flu vaccine trial in the United States. The final phase of the trial will involve 25,000 patients. This is one of the first such trials for an mRNA-based flu vaccine.
Brands and sellers represented on Amazon.com Inc. will be able to send marketing emails to customers.
